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The skeletal fibers have different embryological origin; the extraocular and jaw-closer mus-
cles develop from prechordal mesoderm while the limb and trunk muscles from somites.
These different origins characterize also the adult muscle stem cells, known as satellite
cells (SCs) and responsible for the fiber growth and regeneration. The physiological prop-
erties of presomitic SCs and their epigenetics are poorly studied despite their peculiar
characteristics to preserve muscle integrity during chronic muscle degeneration. Here, we
isolated SCs from canine somitic [somite-derived muscle (SDM): vastus lateralis, rectus
abdominis, gluteus superficialis, biceps femoris, psoas] and presomitic [pre-somite-derived
muscle (PSDM): lateral rectus, temporalis, and retractor bulbi] muscles as myogenic prog-
enitor cells from young and old animals. In addition, SDM and PSDM-SCs were obtained
also from golden retrievers affected by muscular dystrophy (GRMD). We characterized the
lifespan, the myogenic potential and functions, and oxidative stress of both somitic and
presomitic SCs with the aim to reveal differences with aging and between healthy and
dystrophic animals. The different proliferation rate was consistent with higher telomerase
activity in PSDM-SCs compared to SDM-SCs, although restricted at early passages. SDM-
SCs express early (Pax7, MyoD) and late (myosin heavy chain, myogenin) myogenic markers
differently from PSDM-SCs resulting in a more efficient and faster cell differentiation.
Taken together, our results showed that PSDM-SCs elicit a stronger stem cell phenotype
compared to SDM ones. Finally, myomiR expression profile reveals a unique epigenetic
signature in GRMD SCs and miR-206, highly expressed in dystrophic SCs, seems to play
a critical role in muscle degeneration. Thus, miR-206 could represent a potential target for
novel therapeutic approaches.
Keywords: presomitic and somitic satellite cells, differentiation, dystrophic muscle, microRNA
INTRODUCTION
Satellite cells (SCs) are quiescent adult stem cells and they are
located between the basal lamina and sarcolemma of myofibers
(Mauro, 1961). Since SCs function to repair skeletal muscle
damaged by injury or disease, they are responsible for muscle
preservation and growth.
Satellite cells exhibit limited gene expression and protein syn-
thesis due to extremely low cellular turnover (Rando, 2006) and
upon activation they leave the quiescent state and move outside of
the basal lamina, enter the cell cycle and proliferate. The prolifer-
ating SCs, known as myogenic progenitor cells, co-express Pax7
and MyoD, and undergo multiple rounds of division (Chargé
and Rudnicki, 2004). Subsequently, SCs withdraw from the cell
cycle down-regulating Pax7 and expressing myogenin in order to
differentiate into multinucleated myofibers. A limited number of
SCs maintain Pax7 for self-renewing and enter again a quiescent
state. The fact that activated SCs can loose the expression of myo-
genic markers or eventually leave the cell cycle shows that they
are a heterogeneous mixture of stem cells and committed progen-
itors. The myogenic commitment of SCs is finely regulated by the
expression of a temporal class of myogenic transcription factors
(MRFs), which are important for the renewal of SCs (Porter et al.,
2006; McLoon et al., 2007) or for determining their differentia-
tion. However, the signaling pathways that maintain or suppress
SCs at different functional states are largely unknown and recent
studies have emphasized the role of microRNAs (miRNAs) as
novel post-transcriptional modulators of myogenic gene expres-
sion (Drummond et al., 2010). miRNAs are small non-coding
RNAs that negatively regulate gene expression by binding mRNA
target and interfering with protein synthesis, also by reducing the
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accumulation of target messengers. A recent analysis found that
between 74 and 92% of the transcriptome is potentially regulated
by miRNAs (Miranda et al., 2006).
Emerging evidence has demonstrated that miRNAs are essential
for several biological functions including homeostasis, apoptosis
(Huang et al., 2012), and deleterious changes in miRNA expres-
sion are associated with human diseases (Chen et al., 2008). Several
muscle-specific miRNAs in heart and skeletal muscle (myomiRs)
including miR-1, miR-26a, miR-125b, miR-133, miR-206, miR-
208, etc. (McCarthy and Esser, 2007; Small et al., 2010) are con-
sidered important for myoblast differentiation, proliferation, and
muscle remodeling. Among the various myomiRs, miR-1 and
miR-133 are involved in the modulation of muscle growth and
differentiation, while miR-206 specifically promotes muscle myo-
genesis. The regulation of these myomiRs is controlled by MRFs, as
MyoD and myogenin (Rao et al., 2006). SC regenerative potential
is impaired in Duchenne muscular dystrophies (DMD), a recessive
X-linked form of muscular degeneration, and in age-related loss of
muscle mass, i.e., a condition known as sarcopenia (Snijders et al.,
2009). In DMD patients, the SC-mediated regenerative process is
not sufficient to rescue the phenotype, resulting in a general tissue
inflammation. This culminates in continuous cycles of degenera-
tion/regeneration that finally deplete the pool of skeletal muscle
stem cells. However, masseter (Mas), extraocular, laryngeal, and
pharyngeal muscles are less affected during sarcopenic and dys-
trophic degeneration. These muscles present peculiar isoforms of
myosin heavy chain (MyHC) proteins, as MyHC 2B, EO, alpha-
cardiac, and M. For this peculiarity, some authors refer to cranial
facial muscles as “special muscles” (Sciote et al., 1994; Toniolo
et al., 2008; Schiaffino and Reggiani, 2011). The embryonic origin
of these special muscles is the presomitic mesoderm while trunk,
leg, and arm muscles derive from somites. As described by Biressi
and Rando (2010), signaling pathways responsible for myogenic
differentiation of SCs isolated from trunk and special muscles are
different. Interestingly, eye extrinsic muscles responsible for com-
plex and highly coordinated movements do not show signs of
sarcopenia and are not affected by DMD (McLoon et al., 2007).
The muscular dystrophy golden retriever (GRMD) dog is the
closest pathological counterpart of DMD patients (Collins and
Morgan, 2003). In addition, sarcopenia is an emerging syndrome
of importance in dogs (Freeman, 2012). Here, we report for the
first time the characterization of SCs isolated from presomitic
muscles of young, old, and GRMD dogs. We focus on stem cell
properties during aging and in the dystrophic context, highlighting
the epigenetic signature of SC-myotube transition.
MATERIALS AND METHODS
SAMPLING OF CANINE BIOPSIES
Muscle biopsies were collected from different institutions involved
in this study: (1) Veterinary University Clinics in Padua; (2) Vet-
erinary School of Maison-Alfort, Paris. In Padua, the samples
were obtained from dogs that had been euthanized in the Veteri-
nary University Clinics. Those dogs were diagnosed as terminally
ill following accidents. The muscle tissues were collected dur-
ing the normal surgical procedures. Biopsies from GRMD were
obtained from the Veterinary School of Maison-Alfort (Paris,
France). All GRMD dogs considered in this study (see Table 1)
Table 1 | Summary of canine muscle biopsies.
Group Dog Muscle biopsies Age Embryonic origin
HEALTHYYOUNG DOGS
#1 Rectus abdominis 1 year Somites
#2 Gluteus superficialis 3 years Somites
Rectus abdominis Somites
#3 Rectus abdominis 10 months Somites
#4 Biceps femoris 8 months Somites
#5 Extraocular 1 year Presomitic cranial
mesoderm
Vastus lateralis Somites
#6 Extraocular 5 months Presomitic cranial
mesoderm
Vastus lateralis Somites
#7 Extraocular 1 year Presomitic cranial
mesoderm
Vastus lateralis Somites
#8 Rectus abdominis 1 year Somites
Vastus lateralis Somites
HEALTHY AGED DOGS
#9 Psoas 9 years Presomitic cranial
mesoderm
Temporalis, M fiber Presomitic cranial
mesoderm
Rectus lateralis Presomitic cranial
mesoderm
#10 Masseter 18 years Presomitic cranial
mesoderm
Rectus lateralis Presomitic cranial
mesoderm
Retractor bulbi Presomitic cranial
mesoderm
#11 Rectus abdominis 13 years Somites
Vastus lateralis Somites
GRMD
#12 Extraocular 1 year Presomitic cranial
mesoderm
Vastus lateralis Somites
#13 Extraocular 1 year Presomitic cranial
mesoderm
Vastus lateralis Somites
were maintained until natural death, and underwent necropsy
only upon decease. The muscle sampling was done according to
Institutional Animal Care and Use Committee recommendations
and according to the local ethical rules and the Declaration of
Helsinki. The muscles were divided according to their embryonic
origin, MyHC isoform composition, and the anatomical location
(Table 1). Trunk and limb muscles: vastus lateralis (VL), psoas,
rectus abdominis (RA), gluteus superficialis (GS), biceps femoris
(BF) as somite-derived muscles (SDM). Head muscles: rectus lat-
eralis (RL), retractor bulbi (RB), temporalis-M fiber (MT), Mas as
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pre-somite-derived muscle (PSDM). GRMD SCs were collected
only from young dog, while samples from wild-type (WT) dogs
were collected from dogs of different ages.
ISOLATION AND CULTURE OF CANINE SCs
Satellite cells were isolated from muscle tissues stored in liquid
nitrogen in FBS (# ECS0100187, Euroclone, Milan, Italy)+ 10%
of DMSO (#D5879, Sigma-Aldrich, Milan, Italy). Frozen dis-
sected muscle biopsies were thawed at 37°C and washed with
PBS. Under sterile condition, few drops of enzymatic solution
of 0.4 mg/ml collagenase type V (#C9263, Sigma-Aldrich, Milan,
Italy), 0.6 mg/ml pancreatin (#P3292, Sigma-Aldrich, Milan, Italy)
dissolved in PBS (# ECB4004L, Euroclone, Milan, Italy), filtered
using a sterile syringe filter of 0.2µm pore size, stored at 4°C
until use. The solution was added and the muscles were minced
to fine slurry using a scalpel. After transferring the minced tis-
sue into 50 ml tubes, 10 ml of enzymatic solution was added
and incubated at 37°C in a shaking incubator for 30 min. After
gravity sedimentation, the supernatant was collected into new
falcon tube, through filtration by 100µm cell strainer; the diges-
tion was stopped by adding an equal volume of filtered FBS. The
cell suspension was centrifuged at 1200 rpm for 5 min, the super-
natant was discarded and the cells were resuspended in growth
medium (GM). GM contains (% vol/vol): DMEM high glucose (#
ECB7501L,Euroclone,Milan, Italy),0.1 gentamicin (# ECM0011B,
Euroclone, Milan, Italy), 20 FBS, 1 MEM NEAA 100× (#11140,
GIBCO, Life Technology, Carlsbad, CA, USA), 1 sodium pyruvate
100 mM (#11360, GIBCO, Life Technology, Carlsbad, CA, USA),
1 penicillin/streptomycin 100× (# ECB3001D, Euroclone, Milan,
Italy), 1 l-glutamine 100× (#25030-024, GIBCO, Life Technology,
Carlsbad, CA, USA), 2 chicken embryo extract (#2850145, MP,
Santa Ana, CA, USA), 2 heat-inactivated HS (# ECS0091L, Euro-
clone, Milan, Italy) (56°C, 36 min) plus 5 ng/ml bFGF (# PHG0026,
GIBCO, Life Technology, Carlsbad, CA, USA) in PBS. Canine cells
were pre-plated for 1 h on uncoated petri dishes to permit the
attachment of fibroblasts. Unattached cells were transferred to col-
lagen I-coated 60 mm cell culture dish. Five days later, small round
and poorly adhering cells appeared on collagen coated-plates and
were allowed to proliferate in GM until reaching 70–80% conflu-
ence. The cells were either cryoconserved or expanded for further
analysis. To generate batches, 70–80% confluent SCs were frozen
for long-term storage at density of 106 cells/ml in liquid nitro-
gen. To expand the culture, SCs were plated again until reaching
80% confluence and then again detached (passage). The popula-
tion doubling level (PDL) was calculated at each passage with the
following equation: log10(N /n)/ln2 with N as the number of cells
at the time of the passage and n as the number of cells initially
plated. At first passage, all SC populations were considered to be as
1 PDL and we evaluated the maximal PDL reached by the cultures.
SC PROLIFERATION ANALYSIS BY EDU (5-ETHYNYL-2′-DEOXYURIDINE)
FLOW CYTOMETRY
Cells were plated in six well at density of 5× 104/well; after 24 h the
cells were treated with 100µM H2O2 (Sigma). The flow cytometry
method was performed at 24 and 48 h after treatment with hydro-
gen peroxide. Briefly, 10µM Edu was added to the culture medium
for 2 h; after the cells were harvested and washed twice with 1%
BSA in PBS. The cells were fixed with 2% paraformaldehyde in
PBS for 15 min at RT. After wash, the cell pellet was resuspended
with permeabilization solution and incubated with FxCycle Vio-
let for DNA stain. After an incubation period of 15 min at 37°C
in the dark, cells were transferred on ice until analysis with FACS
Calibur™ (BD, USA).
CELL DIFFERENTIATION
Skeletal muscle differentiation was induced by culturing 5,000
cells/cm2 in differentiative medium (DM) for 7 days in the same
medium. DM contains (% vol/vol): DMEM high glucose, 0.1 gen-
tamicin, 5 heat-inactivated HS (56°C, 36 min), 10µg/ml insulin,
100µg/ml apo-transferrin (#T-2036, Sigma-Aldrich, Milan, Italy),
1 MEM NEAA 100×, 1 sodium pyruvate 100 mM, 1 peni-
cillin/streptomycin 100×, 1 l-glutamine 100×. The fusion index
(FI) was calculated as the ratio of the number of nuclei inside
myotubes to the number of total nuclei in 10–20 fields for each
sample. We considered myotubes exclusively the cells positive for
MyHC with two or more nuclei.
TELOMERASE ACTIVITY
Telomerase activity was assessed by TraPEZE RT Telomerase
Detection Kit (#S7710, Millipore, Merck KGaA, Darmstadt, Ger-
many), according to the recommendations of the manufacturer.
Briefly, cell pellets of the samples were resuspended in CHAPS
lysis buffer and protein concentrations were measured by the
Bradford Assay (#500-0205, Bio-Rad, Bio-Rad Laboratories s.r.l.,
Segrate, Milan, Italy). The quantification of telomerase activity
was obtained from the standard curve of TRS8 template. TRS8
template is an oligonucleotide with a sequence identical to the
oligonucleotide substrate primer extended with eight telomeric
repeats AG(GGTTAG). The kit provided cell pellets as positive
controls. According to the manufacturer’s instructions, we also
performed a negative control for each sample. Negative controls
were obtained incubating samples at 85°C for 10 min prior to the
TRAP assay to inactivate telomerase. For each sample, 100 ng of
total proteins were adjusted to a volume of 2µl by CHAPS lysis
buffer and used for the telomerase activity assay. The quantitative
real-time polymerase chain reactions were performed in 96-well
optical reaction plates (Applied BioSystems, Life Technologies,
Molecular Device, Sunnyvale, CA, USA) using the ABI PRISM
7700 Sequence Detection System. Reactions were carried out in
triplicates using the recommended Titanium Taq Polymerase (BD
Clontech, #639208). The experiments were performed according
to the manufacturer’s instructions. We tested telomerase activity
in SC samples collected at early (II–III) and late (VIII–X) passages
and expressed as log copy number calculated using threshold cycle
values and the standard curve for each sample.
IMMUNOFLUORESCENCE ASSAY
Satellite cells were fixed for immunocytochemistry and immuno-
fluorescence analysis to reveal myogenic markers (MF-20 for
MyHC and Pax7 Abs DSHB, USA; MyoD Abs, Dako, USA) and
Ki67 (Dako, USA). Cells were washed twice with PBS and incu-
bated with 2% PFA (#P6148, Sigma-Aldrich, Milan, Italy) for
10 min at RT. Membrane permeabilization was obtained at RT
in 0.2% of Triton X-100 (#93443, Sigma-Aldrich, Milan, Italy),
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1% BSA (#A9647, Sigma-Aldrich, Milan, Italy) in PBS and non-
specific binding of secondary antibodies was blocked with PBS
containing 5% serum from the species in which the secondary
antibody was produced. Without washing, the cells were incu-
bated for 1 h with primary antibody diluted in 1% BSA–PBS.
Then, cells were washed twice with PBS and incubated in the dark
for 30 min at RT with the secondary antibody, diluted 1:500 in
1% BSA+PBS. Nuclei were stained with DAPI (#D1306, Invitro-
gen, Life Technologies, Molecular Device, Sunnyvale, CA, USA).
Unbound antibodies were washed out with PBS and samples were
mounted and analyzed with a fluorescence Nikon inverted micro-
scope Eclipse Ti-U equipped with a Qicam Fast1354 camera using
Pro-Plus software (Media Cybernetics).
IMMUNOCYTOCHEMISTRY
Immunocytochemistry to reveal desmin protein was performed
using LSAB+ System-AP Universal kit (#K0678, Dako, Dako-
cytomation, Glostrup, Denmark) according to manufacturer’s
protocols.
ISOLATION AND QUANTIFICATION OF microRNA
Small RNA extraction from both SDM and PSDM samples was
performed using the PureLink miRNA isolation kit (#K1570-01,
Invitrogen, Life Technologies, Molecular Device, Sunnyvale, CA,
USA) following manufacturer’s instructions. Briefly, 106 cells were
resuspended in 300µl binding buffer and 300µl of 70% alcohol
was added to the cell lysate. Cell lysate was added to a spin car-
tridge and centrifuged for 1 min at 12,000× g. Seven hundred
microliters of 100% alcohol was added to the supernatant and
centrifuged in a new spin cartridge for 1 min at 12,000× g. The
filtrate was discarded, then 500µl wash buffer was added and cen-
trifuged for 1 min at 12000× g. This procedure was repeated twice.
Sterile RNase-free water (30µl) was added to the spin cartridge
and incubated for 1 min at RT before centrifugation at maxi-
mum speed for 1 min to elute the RNA. The RNA concentration
was quantified using NanoDrop™ spectrophotometer readings of
A260, A260/280, and A260/230 ratios. RNA-free nuclease water
was used as blank.
RT REAL-TIME PCR FOR microRNAs SINGLE ASSAY EXPRESSION
RT-stem-loop real-time PCR was performed to evaluate miR-
NAs relative expression. Assays for miRNA profile analysis were
carried out according to Applied Biosystems protocols (Taq-
Man miRNA assay Kit). Briefly, RT reactions containing 20 ng
of small RNA preparation, specific stem-loop primers for each
miRNA, 1× buffer, dNTPs reverse transcriptase, and RNAse
inhibitor were incubated in Thermocycler for 30 min at 16°C,
30 min at 42°C, 5 min at 85°C, and then held at 4°C. Then, real-
time PCR for miRNA expression levels was performed using
miRNA specific TaqMan probes and TaqMan universal mas-
ter mix in a Eppendorf Mastercycler® ep realplex system in
96-well plates, in triplicate. Expression quantification was nor-
malized vs. miR-16 levels. Taqman-based qPCR were conducted
using miRNA-specific probes (Applied Biosystems) as: has-miR-
1 (UGGAAUGUAAAGAAGUAUGUAU; #002222); has-miR-206
(UGGAAUGUAAGGAAGUGUGUGG; #000510); hsamiR-133a
(UUUGGUCCCCUUCAACCAGCUG; #002246); has-miR-133b
(UUUGGUCCCCUUCAACCAGCUA; #002247); has-miR-16-5p
(UAGCAGCACGUAAAUAUUGGCG; #000391).
The quantitative real-time polymerase chain reactions were
performed in 96-well optical reaction plates (Applied BioSystems)
using the ABI PRISM 7700 Sequence Detection System. Reactions
were carried out in triplicates using the recommended Titanium
Taq Polymerase (#639208, BD Clontech, BD Bioscience, Clontech
Laboratories Inc., San Jose, CA, USA). The relative quantification
of target gene expression was evaluated using the arithmetical for-
mula 2−∆∆Ct, according to the comparative C t method, which
represents the amount of target, as normalized to the miR-16
endogenous control. The samples were analyzed as means of the
log base-10 of the ratios, log2 differentiated/undifferentiated. The
data were reported as Log10 RQ, in which upregulated miRNAs
have positive values and downregulated miRNAs have negative
values.
RELATIVE QUANTIFICATION OF MYOGENIC FACTOR GENES BY RT
REAL-TIME PCR
Total RNA from isolated canine SCs was extracted using the
Trizol reagent (Invitrogen, Paisley, UK), according to the man-
ufacturer’s protocol, from about 106 cells. To assess the integrity
and the amount of the RNA extracted, denaturing agarose gel elec-
trophoresis and spectrophotometric A260/280 readings were per-
formed. Two micrograms of total RNA was reverse transcribed into
cDNA with the Superscript III kit (Invitrogen) after treatment with
DNAse I (Invitrogen) to remove contaminating genomic DNA.
Real-time PCR reactions were achieved using an ABI 7500 real-
time PCR System (Applied Biosystems, Foster City, CA, USA) with
the following conditions: 1× PowerSybrGreen Master mix (con-
taining buffer, dNTPs, SybrGreen I dye and AmpliTaq Gold®DNA
Polymerase),300 nM forward and reverse primers each,1µl cDNA
in 20µl total volume. PCR primers for the specific target genes
and for the housekeeping gene (β-actin) were designed using the
Primer Express 3.0 software (Applied Biosystems). All the primer
sequences (Table 2) were designed to span introns in the genomic
DNA in order to minimize non-specific fluorescence signals due to
contaminating genomic DNA. Relative quantifications were calcu-
lated using the ∆∆C t method, normalized to the reference gene
(beta actin) and expressed in arbitrary units as fold change as
compared to the calibrator sample (1 unit).
MEASUREMENT OF INTRACELLULAR REACTIVE OXYGEN SPECIES
Cellular reactive oxygen species (ROS) were quantified by the 2,7-
dichlorofluorescein diacetate (DCFH-DA, #D6883, Sigma) assay
using a microplate reader (Fluorometer SPECTRAmax Gemini XS,
Molecular Devices), using excitation and emission wavelengths
of 480 and 530 nm, respectively and analyzed by SOFTmax Pro
software, according to Menghini et al. method (Menghini et al.,
2011).
NBT ASSAY
The NBT assay is based on the reduction of NBT (Nitro blue tetra-
zolium chloride, #N6639, Sigma) in formazan by O−2 . Reduced
formazan is then quantified at the spectrophotometer. In the
presence of potentially antioxidant substances, the superoxide is
detoxified (scavenger action) and decreases the amount of NBT
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Table 2 | Primer sequences for RT real-time PCR.
Gene Forward sequence Reverse sequence
Myf5 5′-CTGTCTGGTCCCGAAAGAAC-3′ 5′-TGATTCGATCCAC
TATGCTG-3′
Myogenin 5′-AGTGACTGCAGCTCCCACAG-3′ 5′-GACGTGAGAGA
GTGCAGGTT-3′
MSTN 5′-CCCGTCAAGACTCCTACAACAG-3′ 5′-AATGCTCTGC
CAAATACCAGT-3′
MyHC 1 5′-CACCAACCTGTCCAAGTTCC-3′ 5′-CCGGGCAGAT
CAAGAGAAGATA-3′
β-actin 5′-CCATCTACGAGGGGTACGCCC-3′ 5′-TGCTCGAAGTCC
AGGGCGACGTA-3′
reduced, hence lower levels of reduced formazan are detected. Cells
(106 cells) were detached, centrifuged 5 min at 170× g and resus-
pended in 1 mg/ml of NBT with 1 ml 0.9% NaCl. Then, the cells
were left for 3 h at 37°C (incubator), centrifuged 10 min at 100× g
in microfuge, resuspended in 1 ml DMSO and left for 20 min at
37°C. For the assay, cells were plated in a 96-well plate (2× 105
cell/well) and assayed at the spectrophotometer at 550 nm on a
scanning multi-well reader (Microplate spectrometer SPECTRA-
max 190, Molecular Devices, Sunnyvale, CA, USA) according to
Sozio et al. (2013).
CALCIUM IMAGING
Satellite cells were plated at a confluence of 6,000 cells/cm2 in
96-well plates (Corning, Tewksbury, MA, USA). The measure-
ments were performed using Fura-2 AM (#F1221, Invitrogen)
as Ca2+ indicator. Myoblasts and myotubes were loaded with
5µM Fura-2 AM in normal external solution (NES) supplemented
with 10 mg/ml of BSA for 40 min at 37°C and 5% CO2. NES
is composed of 10 mM glucose (#454337, Carlo Erba), 140 mM
NaCl (#S7653, Sigma), 2.8 mM KCl (#471177, Carlo Erba), 2 mM
CaCl2, 2 mM MgCl2 (Sigma), and 10 mM HEPES (#101926, ICN,
Biomedicals Inc.), pH 7.4, 290–300 mOsM. After loading, the
cells were rinsed and maintained in NES for 10 min at room
temperature (RT), to allow the de-esterification of the probe.
Myoblasts and myotubes of similar size were selected for mea-
surement and the region of interest (ROI) was drawn around
the cells. Then, living cells were sequentially excited at 340 or
380 nm with a high-speed wavelength switcher Polychrome II (Till
Photonics, Germany). Fluorescence images were collected using a
40× oil objective lens, acquired using an intensified CCD cam-
era (Hamamatsu Photonics, Hamamatsu), stored on a PC, and
analyzed off-line. The acquisition time for each fluorescence emis-
sion was 0.5 s and the background fluorescence was subtracted
from the signal in the ROI. The 340 and 380 traces and 340/380-
ratio were recorded and analyzed using Aquacosmos software
(Hamamatsu).
STATISTICAL ANALYSIS
Unpaired t -test with Welch’s correction and ANOVA as mentioned
in the figure legends, were performed using Prism5 GraphPad
software (Abacus Concepts, GraphPad Software, San Diego, CA,
USA). A p-value <0.05 was considered to indicate statistical
significance.
RESULTS
CANINE SATELLITE CELL CHARACTERIZATION
Following canine muscle biopsies dissociation with enzymatic
solution (as described in Materials and Methods), SCs gave rise
to myogenic progenitor cells in culture. To avoid confusion, we
used SCs throughout the manuscript to indicate also myogenic
progenitor cells, and the list of canine biopsies used to isolate SCs
in our study is reported in Table 1. WT SCs isolated from somitic
(SDM) and presomitic (PSDM) muscles were morphologically
similar (Figure 1A) and were organized in small clones derived
from single cell divisions (Figure 1B). We cultured the cells at
very low density in order to identify single cells. We plated 500
cells (SDM and PSDM) on 100 mm collagen I-coated Petri dishes
and marked those separate cells with a number. By counting the
number of cells per clone, we evaluated the clonogenic ability
of primary cell culture isolated from trunk and head muscles of
young and old dogs. The ability of a single cell to proliferate inde-
pendently to form a colony was similar in samples at comparable
ages (data not shown).
Satellite cells in culture were expanded until replicative senes-
cence was reached and the PDL was calculated. The growth
curves of young (age ranging between 5 and 36 months) and
old (age ranging between 9 and 18 years) showed higher rate
of doubling level in PSDM-SCs with respect to SDM-derived
SCs (Figures 1C,D). This difference was marked in SCs derived
from old dogs (Figure 1D) where SDM-SCs stopped their pro-
liferation at 25 days, after only 20 PDL. Differently, PSDM-SCs
could proliferate longer (until 40 days) and undergo to senes-
cence after about 30 PDL. No significant differences were observed
between old and young SCS derived from comparable muscles.
Figure 1E shows the growth curve of 1-year-old GRMD SCs iso-
lated from SDM and PSDM samples. PSDM-SCs from GRMD
samples (Figure 1E) showed a higher doublings activity in respect
to SDM-SCs. This is probably due to the fact that head muscles
are less affected in dystrophic dogs, and SCs were not exhausted
by multiple attempts to regenerate lost tissue as occurred in more
active muscles.
We tested the telomerase activity in SC samples collected at
early (2, 3 p) and late (8–10 p) passages and expressed as log copy
number calculated using threshold cycle values and the standard
curve for each sample. As shown in Figure 1F, in PSDM-SCs there
was a trend toward a higher telomerase activity (9.0± 0.6) com-
pared with SDM-SCs (8.0± 1.0) at early passages. At late passages,
the telomerase activities were similar among all analyzed samples.
Immunofluorescence analysis showed that 10% of PSDM-SCs still
express Ki67 after 30 days in culture, while SDM-SCs were com-
pletely negative (Figure S1 in Supplementary Material). Although
we cannot exclude that SDM-SCs enter in a quiescent status, the
results suggest that PSDM-SCs can still proliferate after 30 days
while SDM-SCs cannot. In addition, large nuclei in SDM-SCs
are further indicating senescent cells (De Cecco et al., 2011) as
indicated in Figure S1 in Supplementary Material, inset and right
panels.
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FIGURE 1 | Characterization of canine satellite cells (SCs).
(A,B) Phase contrast morphology of freshly isolated SCs (A) from
somitic (SDM) and presomitic (PSDM) muscles biopsies;
bar=50µm. SCs were cultured at low density to generate clones
(B) and cells were maintained in culture until they stop to divide;
bar=250µm. Growth curves of (C) SDM- and PSDM-SCs from
young donors; (D) SDM- and PSDM-SCs from old donors; (E) SDM
and PSDM-SCs from dystrophic dogs. Telomerase activity (F) in SCs
collected at early and late passages from SDM and PSDM. Data are
represented as mean±SD.
EXPRESSION OF MYOGENIC REGULATORY FACTORS IN CANINE SCs
Taken into account the SC heterogeneity due to the adopted
enzymatic digestion method, the myogenic index (MI) was esti-
mated as a percentage of desmin (an early myogenic marker)
positive (Desm+) cells and revealed by immunocytochemistry
(Figure 2A). SCs are capable to spontaneously differentiate when
they reach 80–90% of confluence, however in all experiments
we differentiate SCs into myotubes by serum starvation in dif-
ferentiation medium containing 2% horse serum. In general,
PSDM biopsies have a lower content of myogenic cells com-
pared to SDM samples. Age-independent differences have been
found both in WT (Figure 2B, 79.1% in SDM vs. 56.5% in
PSDM of young dogs, and 91.1% in SDM vs. 54.2% in PSDM
of old dogs) and GRMD (72.0% in SDM vs. 47.8% in PSDM)
dogs. By immunofluorescence assay (Figures 2C,D), SDM-SCs
isolated from WT dog showed an higher content of Pax7+ (49.1 vs.
32.5%) and MyoD+ (65.5 vs. 29.0%) cells compared with PSDM-
SCs (Figure 2E); while GRMD SCs displayed an opposite result:
lower content of both Pax7+ (5.5 vs. 25.0%) and MyoD+ (8.0
vs. 54.7%) SDM vs. PSDM-SCs (Figure 2F). In addition, myo-
genin expression resulted upregulated during differentiation in
SCs isolated from SDM and PSDM and its expression was not
affected with aging (Figure 2G). However, in GRMD dogs myo-
genin was upregulated only in PSDM-SCs during differentiation,
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FIGURE 2 | Expression of myogenic markers in canine SCs.
(A) Desmin positive (Desm+) SCs were quantified (B) for WT young
SCs isolated from SDM and PSDM muscle biopsies; for WT old SCs
isolated from SDM and PSDM; similarly the percentage of Desm+ SCs
in SDM and PSDM isolated from GRMD dogs. (C,D) Examples of
immunofluorescence analysis for Pax7 and MyoD of WT SDM-SCs
(C) and PSDM-SCs (D). Quantifications of Pax7 and MyoD positive SCs
(E) normalized to percentage of Des+ from WT SDM and PSDM are
shown; in (F) are reported SCs from dystrophic dogs SDM and PSDM.
Myogenin expression in SCs during differentiation was measured by
quantitative real-time PCR (G). Myogenin is upregulated after 7 days of
differentiation in all samples expect in GRDM SDM-SCs. Three
independent experiments were performed in triplicates and statistically
analyzed using Dunn’s Multiple Comparison Test. MyHC staining
(H) was used to quantify the FI (I) of SCs isolated from SDM and PSDM
of WT young; from SDM and PSDM of WT old and of GRMD SCs
isolated from SDM and PSDM. Data are represented as mean±SD
and statistically analyzed using t -test; *p<0.05. Bar=50µm.
while SDM-SCs failed to increase the expression of myogenin at
day 7 (Figure 2G).
Then, we examined the ability of SCs to fuse into mult-
inucleated myotubes after 7 days in culture with low serum
(2% HS). Figure 2H shows an example of MyHC positive
canine myotubes used for the FI analysis. Young PSDM-SCs
presented a higher FI compared with SDM-SCs (Figure 2I,
58.5 vs. 39.8% in PSDM vs. SDM, respectively). Interestingly,
FI was drastically lower in PSDM-SCs compared to SDM-
SCs isolated from old dogs (4.7 vs. 27.4%, respectively). The
same trend was found in GRMD where SDM-SCs differentiate
more efficiently than PSDM-SCs (60.5 vs. 29.5%). These results
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suggest that SCs isolated from GRMD dogs act similarly as old
WT SCs.
OXIDANT LEVELS IN CANINE SCs
Oxidants such as ROS/RNS are known to affect cell function,
including the ability to differentiate. It has been proposed that
several factors, including ROS, are able to regulate skeletal muscle
gene expression. However, when the levels of oxidants consis-
tently remain high and are not reduced by endogenous scav-
enger systems, as occurring in elderly skeletal muscle (Musarò
et al., 2010), the cell undergoes oxidative stress, which may
affect its ability to differentiate (Beccafico et al., 2007). For this
reason, we analyzed the oxidant levels present in SCs isolated
from muscle biopsies (Figure 3). After an oxidant insult repre-
sented by H2O2, old SCs were less capable to reduce ROS lev-
els (SDM= 148.0± 26%; PSDM= 136.0± 9%) present in cells,
demonstrating a poor antioxidant capacity (Figures 3A,B). Fur-
thermore, the levels of superoxide anion (Figure 3C) were lower
in all SDM-SCs as compared to PSDM-SCs, but in old SCs these
values were very high (SDM= 0.34± 0.01; PSDM= 0.47± 0.04)
as compared to young (SDM= 0.15± 0.01; PSDM= 0.18± 0.01)
and GRMD (SDM= 0.11± 0.01; PSDM= 0.24± 0.01) SCs.
To address whether SCs from PSDM or SDM were still able
to proliferate under stress conditions, we evaluated the effect of
100 nM H2O2 on PSDM- and SDM-SCs by Edu (5-ethynyl-2’-
deoxyuridine) flow cytometry analysis (Figure S2 in Supplemen-
tary Material). The nucleoside analog EdU for thymidine substitu-
tion in cell proliferation assays has recently been proposed in FACS
analysis studies (Diermeier-Daucher et al., 2009). As reported in
Figure S2A in Supplementary Material, PSDM and SDM-SC did
not show any alterations of proliferative capability. However, a
higher number of cells in S phase were observed in PSDM-SCs
compared to SDM-SCs (28 vs. 16% after 24 h and 19 vs. 9%
after 48 h). In addition, cell viability revealed marginal differences
among the analyzed samples and the minimal viability rate was
observed in SDM-SCs at 24 h post treatment (approximately 93%,
Figure S2B in Supplementary Material).
The ability to fuse under stress condition was evaluated by
immunostaining. The H2O2 treatment was sufficient to dra-
matically reduce myogenic differentiation in SDM-SCs while
PSDM-SCs were not affected. This suggests that, differently from
SDM-SCs, PSDM-SCs are resistant to oxidative stress.
RESTING CYTOPLASMIC [CA2+]I
Myogenesis is a strictly Ca2+-dependent process and according to
Bijlenga et al. (2000) the biophysical properties of specific ionic
channels are important actors in the fusion process. We measured
the resting [Ca2+]i in myoblasts derived from somitic and pre-
somitic, young, old, and GRMD muscles. The findings for PSDM
GRMD SCs showed an increasing resting intracellular calcium
concentration (127.0± 18 nM, n= 24) as compared to the somitic
ones (SDM GRMD SCs; 63.5± 10 nM, n= 50) (Figure 3D). On
the contrary, SDM GRMD and SDM WT young had similar con-
tent in cytoplasmic calcium at resting condition (63.5± 10 nM,
n= 24; 65.0± 6 nM, n= 27) (Figure 3D). Likewise, the old SDM-
SCs presented a higher level of resting [Ca2+]i as compared to
FIGURE 3 | Oxidant and calcium levels. Quantification of intracellular
ROS levels by DCFH-DA assay expressed as a percentage respect to CTRL
in SCs isolated from SDM (A,B) PSDM. (C) Quantification of O−2 by rate
reduction of NBT. The OD 550 nm represents the quantity of formazan
revealed spectrophotometrically. (D) Basal levels of [Ca2+]i expressed in
nanomole measured on undifferentiated living cells by video-imaging
technique. Data are represented as mean±SD and statistically analyzed
using t -test; *p<0.05; **p< 0.0001.
young and GRDM, but differently from those that did not show
an increase of Ca2+ level in PSDM.
CA2+ TRANSIENT INDUCED BY EXTRACELLULAR STIMULI
To verify the presence of functional receptors, Ca2+ imaging exper-
iments were performed on single myoblasts isolated from somitic
and presomitic muscles, young, old, and GRMD. The physiologi-
cal agents used on living cells were: (1) 100µM ATP, which mainly
causes a release of Ca2+ via IP3/PKC (protein kinase) pathway in
muscle cells; (2) 400µM nicotine, which acts on nicotine recep-
tors, a typical channel of neuromuscular junction; (3) 40 mM KCl,
which induces a chemical depolarization of external membranes
on myotube.
As shown in Table 3, all samples analyzed were responsive to
100µM ATP with no significant differences, demonstrating that
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Table 3 | Small molecule responsiveness of undifferentiated SCs;
values are expressed as a percentage.
Young Old GRMD
SDM PSDM SDM PSDM SDM PSDM
Nicotine 0 90 3 80 50 65
KCl 6 0 3 35 4 66
ATP 100 65 93 65 100 56
the release of calcium via IP3 pathway was unaffected by aging, or
disease, or embryonic origin of SCs.
Surprisingly, a high percentage of stimulated cells of young
(90%), old (80%), and GRMD (65%) from PSDM were responsive
to 400µM nicotine, revealing the presence of cholinergic receptors
on the external membrane of undifferentiated cells. Furthermore,
PSDM-SCs from old (35%) and GRDM (65.0%) dogs were also
shown to respond to depolarizing stimulus (40 mM KCl).
MUSCLE-SPECIFIC miRNAs IN WT CANINE SCs
Some miRNAs are involved in post-transcriptional regulation of
gene expression during skeletal muscle development. Therefore,
we examined the expression of miR-1, miR-206, miR-133a, miR-
133b (Figures 4–6), collectively known as myo-miRNAs and using
miR-16 ubiquitously expressed as internal control. The results
reported in Figures 4A,B showed no differences in miR-133a and
miR-133b expression after 7 days of differentiation (t7) in isolated
SCs from young SDM. However, we found that miR-133a and
miR-133b were highly expressed in PSDM-SCs upon differentia-
tion. The myogenic miR-1 was slightly upregulated at t7 only in
PSDM-SCs from young donors (Figure 4C). miR-206 was simi-
larly expressed in young PSDM- and to SDM-SCs (Figure 4D).
With aging, the expression levels of miR-133a (Figure 5A) and
miR-133b (Figure 5B) resulted affected and old PSDM-SCs did
not positively regulate those miRNAs, whereas the expression of
miR-1 was not modified in PSDM-SCs from old dogs (Figure 5C).
Also, miR-206 in PSDM-SCs from old donors was found downreg-
ulated as compared to values from young donors and not modified
during myogenic differentiation (Figure 5D). In summary, the
expressions of myomiRs appeared to be modulated in SCs isolated
from PSDM and this phenomenon seems to be age-dependent.
MUSCLE-SPECIFIC miRNAs IN GRMD SCs
Recent studies have shown that changes in miRNA expressions
are associated with various skeletal muscle disorders, including
muscular dystrophy (Eisenberg et al., 2009; Williams et al., 2009).
However, the contradictory literature motivated the investigation
for the expression profile of myomiRs during myogenic differ-
entiation of dystrophic SCs. In fact, some authors referred to
myo-miRNAs as markers of muscle regeneration while others sup-
port their critical role to sustain muscle degeneration. As for WT
SCs, we studied the expression of myogenic miRNAs in SCs iso-
lated from SDM and PSDM of GRMD dogs. As shown in Figure 6,
miR-133a and miR-133b were upregulated at day 7 in SCs isolated
from GRMD PSDM (Figures 6A,B). This result was consistent
with WT expression. In addition, similarly to WT cells, miR-133a
FIGURE 4 | Relative miR-133a, miR-133b, miR-1, and miR-206,
expression in canine SCs measured by quantitative real-time PCR. SCs
were isolated from SDM and PSDM of young dogs. Note that miR-133a (A)
and miR-133b (B) are upregulated only in PSDM-SCs after 7 days of
differentiation (t7). miR-1 is upregulated only in PSDM-SCs (C) after 7 days
of differentiation. At variance, miR-206 is highly expressed in PSDM-SCs
during proliferation (D). The ubiquitously produced miR-16 was used as an
internal control. Three independent experiments were performed in
triplicates and statistically analyzed using ANOVA. Data are presented as
mean±SD; *p< 0.05.
and miR-133b were not upregulated in SDM-SCs upon differenti-
ation (Figures 6A,B). Likewise, miR-1 and miR-206 were markedly
upregulated in PSDM-SCs after 7 days of differentiation in GRMD
dogs (Figures 6C,D) and not in GRDM SDM-SCs (Figures 6C,D).
The expression profile of myomiRs appeared to be affected by
the dystrophic niche and miR-206 miR-1 seem to be primarily
involved since they are highly expressed in differentiated SCs from
both SDM and PSDM of GRMD samples.
DISCUSSION
In the last decades, SCs have been shown as muscle stem cells
responsible for tissue regeneration in adulthood (Scharner and
Zammit, 2011). Most of clinically relevant protocols for testing
potential therapeutic approaches have been performed in small
animal models, meaning mice and rats (Blau, 2008; Kuang and
Rudnicki, 2008). However, large animal models have been consid-
ered essential to better mimic human diseases, to validate outcome
measures, and to obtain reliable protocols for novel pharmaceuti-
cal, gene, and cell therapies. Thus, GRMD dogs represent a valuable
large animal model to perform preclinical studies (Kornegay et al.,
1988; Sharp et al., 1992). However, our knowledge on biolog-
ical behavior of muscle regeneration in canine tissues remains
primitive and requires further investigations.
In this work, extensive analysis for the biological properties
of WT (young and old) and GRMD SCs isolated from somitic
(SDM) and presomitic (PSDM) muscles are carried out. Although
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FIGURE 5 | Relative miR-133a, miR-133b, miR-1, and miR-206,
expression in old canine PSDM-SCs measured by quantitative
real-time PCR. In old PSDM-SCs, miR-133a (A) and miR-133b (B) are
downregulated in both proliferating and differentiating cells. miR-1 and
miR-206 regulations seem age-dependent, since old PSDM-SCs did not
upregulate miR-1 during differentiation (C), while miR-206 is not highly
expressed during proliferation (D). The ubiquitously produced miR-16 was
used as an internal control. Three independent experiments were
performed in triplicates and statistically analyzed using ANOVA; Data are
presented as mean±SD; *p<0.05.
the gross morphology is quite similar in these muscles, several
studies revealed unexpected molecular and cellular differences
depicting peculiar biological characteristics in proliferation, lifes-
pan, and differentiation potential of SDM and PSDM-SCs (Ono
et al., 2010). With enzymatic dissociation it was possible to isolate
SCs in all biopsies obtained by different research centers includ-
ing Ecole de Veterinaire Maison-Alfort, Veterinary and University
Clinics of Padua. In general, there were no observed differences
in terms of SC quality, among the samples obtained by fresh or
frozen biopsies. The proliferative lifespans of SCs derived from
SDM and PSDM in both WT and GRMD dogs at different ages
was also considered and compared. While the proliferative ability
of SCs isolated from young SDM was approximately 20 population
doublings before replicative senescence, SCs from young PSDM
had 25 divisions in vitro. These differences were remarkable in
WT old muscle as SCs isolated from PSDM stop to proliferate
after 28 divisions while the cells derived from SDM had only 18
divisions. At later stage although SDM-SCs isolated from GRMD
biopsies were phenotypically indistinguishable from WT SCs in
ex vivo cultures, the cells showed a slower proliferative rate com-
pared to the young WT SCs. Indeed, after 40 days they reached
about 18 divisions compared to 30 days necessary to SDM-SCs
isolated from WT samples. These findings suggest that SDM-SCs
in GRMD dogs were exhausted by multiple attempts to regenerate
lost tissues resulting in a limited proliferative ability. Nevertheless,
they were prone to differentiate into myotubes much faster when
FIGURE 6 | Relative miR-133a, miR-133b, miR-1, and miR-206
expression in GRMD SCs measured by quantitative real-time PCR. SCs
were isolated from SDM and PSDM of GRMD dogs. Consistent with data
obtained with WT canine SCs, miR-133a and miR-133b are highly expressed
after 7 days of differentiation in PSDM-SCs. At variance, miR-133a and
miR-133b are upregulated in SDM-SCs after 7 days of differentiation (A,B).
Intriguingly, miR-1 and miR-206 are highly upregulated after 7 days of
differentiation in PSDM-SCs (C,D). Three independent experiments were
performed in triplicates and statistically analyzed using ANOVA; miR-16 was
used as an internal control. Data are presented as mean±SD; *p<0.05.
compared to their WT counterparts. It is possible that when cul-
tured in vitro they recapitulate their in vivo needs, i.e., to faster
replace damaged myofibers. In this view, several articles recently
showed a potential cell memory in reprogrammed cells (Kim et al.,
2010; Polo et al., 2010; Quattrocelli et al., 2011). Our group also
previously proposed that the SC pool is affected by the same
lifestyle or pathological condition of the muscle in which they
reside (Fulle et al., 2004). Similarly, SCs generated from degen-
eration/regeneration cycles appear to adapt to their biological
behavior to better counteract the following degenerative processes
(La Rovere et al., unpublished observation).
After isolation SCs are characterized by a period of rapid growth
upon serial passages, until their proliferation rate gradually slows
down and ultimately enters a non-dividing state called replicative
senescence (Allsopp et al., 1995). Each cell division is characterized
by a decrease of telomerase length and that has been proposed as a
mitotic clock that regulates proliferative capacity of somatic cells
in vitro (Di Donna et al., 2000). Thus, the higher telomerase activ-
ity observed in PSDM-SCs supports the hypothesis that those cells
preserve a better proliferation capability compared to SDM-SCs,
and consistently their lifespan is prolonged.
In our study, desmin expression was used as internal standard
for normalization to avoid misinterpretation of comparative eval-
uations. Generally, low content of myogenic cells were obtained
from head muscles compared to somite muscles and this difference
was independent of sample age and between WT and GRMD. The
FI and skeletal muscle differentiation potential of WT and GRMD
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SCs was evaluated and analyzed. Our data show that WT limb
muscles (SDM) contained a higher percentage of activated SCs
compared to PSDM, as indicated by Pax7 and MyoD expression
analysis. Conversely, SDM-SCs from GRMD dogs showed a lower
percentage of Pax7 and MyoD positive cells, whereas craniofacial
muscle (PSDM) contained significantly higher numbers of Pax7
and MyoD positive SCs. Overall, our analyses strongly support
the idea that PSDM-SCs retain a higher myogenic potential com-
pared to the SDM-SCs isolated from GRMD muscles. Despite a
higher number of MyoD positive cells in PSDM-SCs isolated from
GRDM dogs, they show less differentiation capacity compared to
the WT counterparts.
To verify if PSDM-SCs have an intrinsic capability to resist
to toxic insults, or whether their invulnerable behavior can be
justified from specific niche characteristics, the response of both
PSDM-SCs and SDM-SCs to hydrogen peroxide treatment has
been assessed. Notwithstanding that the proliferation ability of
SCs from PSDM and SDM samples were not affected, 100 nM
H2O2 treatment impaired the myogenic differentiation exclusively
in SDM-SCs.
To fully investigate if this reduced differentiative capability was
due to high oxidant levels, ROS contents have been evaluated.
Although for a long time the ROS formation has been believed
harmful, evidences are accumulating showing the key role of ROS
presence and production in cell signaling. In addition, changes in
ROS content seem to be modulated during myogenic processes
(Musarò et al., 2010). It was previously observed that human
SC derived from old subjects showed to have a high oxidative
stress with respect to young samples (Fulle et al., 2004; Beccafico
et al., 2007; Pietrangelo et al., 2009). This was associated to higher
[Ca2+]i, probably due to alteration of calcium homeostasis reg-
ulatory proteins functionality. Here, it is confirmed that elderly
SDM and PSDM canine SCs showed high ROS levels, however,
dystrophic SCs displayed ROS levels similarly to young WT sam-
ples. In all PSDM-SCs, high responsiveness to nicotine determined
the characteristic calcium transients and revealed the presence of
nicotinic receptors on undifferentiated cells (Krause et al., 1995).
SCs express low levels of functional nicotinic acetylcholine recep-
tors (nAChR) before myosin becomes detectable (Grassi et al.,
2004) and considered to be an early marker of myogenic differen-
tiation. Thus, this opens up new cues to examine presomitic aged
and dystrophic SCs that showed to still remain functional and able
to fuse with existing fibers.
To date, the crucial miRNAs involved in skeletal muscle dif-
ferentiation are miR-1, miR-206, miR-133a, miR-133b and are
collectively known as myomiRs. miR-1 and miR-206 are key myo-
miRNAs for Mef2c-dependent terminal myogenic differentiation.
miR-1 and miR-206 act as positive controls for the progression
of differentiation via Notch 3 and utrophin inhibition (Rosen-
berg et al., 2006; Gagan et al., 2012). Several studies have shown
that changes in miRNA expressions are associated with various
skeletal muscle disorders, including muscular dystrophy (Eisen-
berg et al., 2009; Williams et al., 2009). Thus, we examined the
expression of myomiRs during proliferation (day 0) and differ-
entiation (day 7) of SCs isolated from WT and GRMD samples.
Our data showed that miR-133a and miR-133b, involved in early
myogenic differentiation, were upregulated after 7 days of differ-
entiation in WT PSDM. However, this upregulation disappeared
with aging and the PSDM-SCs acted similarly to SDM-SCs. miR-1
is also upregulated at day 7 in WT PSDM-SCs and again aging
affected negatively its modulation. miR-206 is highly expressed in
young WT PSDM samples while in aged samples it is much less
expressed. Overall from the collected results, myomiRs are clearly
modulated in PSDM-SCs of WT canine muscles and this regula-
tion is lost with aging. In the GRMD, a similar modulation for
miR-133a, miR-133b, and miR-1 was found in the PSDM-SCs.
In addition, miR-206 was strongly upregulated at day 7 of dif-
ferentiation. Intriguingly, myomiR upregulation was observed in
SDM-SCs of GRMD dogs that feature worse locomotion ability.
In this view, myomiR overexpression could sustain the muscle
chronic degeneration of GRMD dogs by affecting the expression
of myomiR target genes.
Emerging literature confirmed that the expression of miR-206
is essentially confined to skeletal muscle (Baskerville and Bartel,
2005; Liang et al., 2007) and involved in muscle differentiation
by repressing the expression of DNA polymerase A, connexin 43,
follistatin-like 1, and utrophin. Intriguingly, miR-206 was found
highly expressed in the diaphragm of mdx mouse, the murine
counterpart of GRMD dogs, and not in the hindlimb muscles
(McCarthy et al., 2007). This result is significant because the
diaphragm of the mdx mouse displays DMD phenotype differ-
ently from hindlimb muscles. McCarthy et al. (2007) proposed
that increased miR-206 expression may contribute to the chronic
pathology of mdx diaphragm. In fact, miR-206 represses the
expression of genes, including utrophin, that otherwise would
serve as compensatory function. Utrophin is indeed a verified tar-
get of miR-206, and this observation explains at least in part the
higher expression of utrophin protein in the mdx hindlimb mus-
culature where miR-206 is barely detectable. Conversely, Eisenberg
et al. (2007) showed recently the expression profiling of 10 different
human dystrophies, including DMD, in which miR-206 expression
was similar to one observed in control muscles. One possible expla-
nation for this discrepancy is again the different muscles used to
evaluate miRNA expressions. In conclusion, the expression profile
of MRFs and myomiRs reveals a unique molecular signature in
canine SCs. In addition, miR-206 seems to be primarily involved
in GRMD SC impairment, although its precise role needs to be
carefully considered in the light of discordant literature.
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SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at http://www.frontiersin.org/Journal/10.3389/fnagi.2014.00090/
abstract
Figure S1 | Immunofluorescence analysis for Ki67 expression in early and
late passages of SC cultures. Examples of Ki67 staining indicating that up to
30% of SCs are proliferating in both SDM and PSDM samples. Consistent with
growth curve data at late stage (30 days) while up to 10% of PSDM-SCs (22
PDL) are still positive for Ki67, SDM-SCs (20 PDL) stopped proliferation and the
majority of cells present large nuclei (red arrow heads). Ki67 positive nuclei
(green arrow heads) are much smaller compared to negative ones (right lower
panel). Bar=100µm.
Figure S2 | Effect of hydrogen peroxide on SC differentiation. SCs were
isolated from SDM and PSDM of WT dogs and harvested after 24 and 48 h of
treatment with 100 nM hydrogen peroxide. SCs did not show any differences
under this condition. However, a higher number of cells in S phase were
observed in PSDM-SCs compared to SDM-SCs (28 vs. 16% after 24 h and 19
vs. 9% after 48 h) (A). Cell viability was assessed using Countess Automated
Cell Counter (Life Technologies) after trypan blue staining (B). The H2O2
treatment was sufficient to dramatically reduce myogenic differentiation in
SDM-SCs while PSDM-SCs were not affected (C). Bar=100µm.
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